- Elicio Therapeutics (ELTX) priced a $15M registered direct offering led by two new fundamental institutional investors, with participation from an existing large shareholder.
- The clinical-stage biotechnology company agreed to sell about 4.38M shares of common stock in the offering.
- Net
Elicio Therapeutics drops 5%, prices $15M direct offering (ELTX:NASDAQ)
